JAMA Neurology : Fremanezumab for the Treatment of Migraine and Major Depressive Disorder
- Author
- American Medical Association, 2017
- Published
- Mon 05 May 2025
- Episode Link
- https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jamaneurol.2025.1368
Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD.
Related Content:
